Plasma Cell Disorders Meeting 2019

This is a clinically oriented lecture with the intention of allowing oncologists and other cancer health care providers to learn more about the biology and diagnostics of Plasma Cell Disorders and the latest innovations in treating them.

Target Audience

Hematological oncologists, clinical oncologists, and other cancer healthcare providers, including NPs, PAs, and RNs. 

Educational Objectives

Following this program, participants should be able to:


Knowing and Finding the enemy

In this lecture Maximilian Merz, MD, looks at the criteria of diagnostics for myeloma disease as well as available treatments.

Mapping the Battlefield: Imaging of Multiple Myeloma

Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.
Jens Hillengass, MD

Jens Hillengass, MD

Chief of Myeloma, Professor of Oncology

Getting Out the Big Guns: Transplant and Cellular Therapy

Phillip McCarthy, MD, discusses autologous stem cell transplant/rescue following induction therapy, available therapies, and why a majority of patients will have progressive disease.
Philip McCarthy, MD

Philip McCarthy, MD

Professor of Oncology and Internal Medicine
Director, Transplant & Cellular Therapy Center, Department of Medicine

Finding New Weapons: Novel Treatment Approaches in Myeloma

Kelvin Lee, MD, gives a “philosophical talk” regarding novel treatment approaches in myeloma. This lecture helps illustrate the way doctors think about drugs and treatments for treating myeloma.
Kelvin Lee, MD

Kelvin Lee, MD

Chair, Department of Immunology

Caring for the Wounded: Treatment of Myeloma Bone Disease 1

Ryan Hare, PharmD, discusses the treatment of Myeloma Bone Disease. This lecture will review the myeloma bone microenvironment, discuss bone preservation benefits of treatments, describe aniti-myeloma properties, and highlight medication ...
Ryan Hare, PharmD

Ryan Hare, PharmD

Clinical Pharmacist

Caring for the Wounded: Treatment of Myeloma Bone Disease 2

Hillary Jacobson, DPT, shares the importance of exercise in reducing fatigue in patients diagnosed with cancer.
Hillary Jacobson, DPT

Hillary Jacobson, DPT

Physical Therapist